Literature DB >> 15913650

The oligomeric structure of vaccinia viral envelope protein A27L is essential for binding to heparin and heparan sulfates on cell surfaces: a structural and functional approach using site-specific mutagenesis.

Yu Ho1, Jye-Chian Hsiao, Min-Hsiang Yang, Che-Sheng Chung, Yu-Chang Peng, Ta-Hsien Lin, Wen Chang, Der-Lii M Tzou.   

Abstract

The soluble domain of the self-assembly vaccinia virus envelope protein A27L, sA27L-aa, consists of a flexible extended coil at the N terminus and a rigid hydrophobic coiled-coil region at the C terminus. In the former, a basic strip of 12 residues is responsible for binding to cell-surface heparan sulfates. Although the latter is believed to mediate self-assembly, its biological role is unclear. However, an in vitro bioassay showed that peptides comprising the 12 residue basic region alone failed to interact with heparin, suggesting that the C-terminal coiled-coil region might serve an indispensable role in biological function. To explore this structural and functional relationship, we performed site-specific mutagenesis in an attempt to specifically disrupt the hydrophobic core of the coiled coil. Three single mutants, L47A, L51A, and L54A, and one triple mutant, L47,51,54A, were expressed and purified from Escherichia coli. The physical properties of the mutants were carefully examined by gel-filtration chromatography, CD, and NMR spectroscopy, and the biological activities were assessed by an in vitro SPR bioassay and three in vivo bioassays: binding to cells, blocking virus infection and blocking cell fusion. We showed that the L47A mutant, which is similar to the parental sA27L-aa in forming a hexamer, is biologically active. L51A and L54A mutants form tetramers and are less active. Notably, in the triple mutant, the self-assembly hydrophobic core structure is uncoiled; as a consequence, the tetrameric structure is biologically inactive. Thus, we conclude that the leucine residues, in particular Leu51 and Leu54, sustain the hydrophobic core structure that is essential for the biological function of vaccinia virus envelope protein A27L, binding to cell-surface heparan sulfate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913650     DOI: 10.1016/j.jmb.2005.04.024

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry.

Authors:  R Jeremy Nichols; Eleni Stanitsa; Bethany Unger; Paula Traktman
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

2.  Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17.

Authors:  Da-Rong Wang; Jye-Chian Hsiao; Chien-Hsuan Wong; Guo-Chian Li; Su-Ching Lin; Steve S-F Yu; Wenlung Chen; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

3.  Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.

Authors:  Christiana N Fogg; Jeffrey L Americo; Patricia L Earl; Wolfgang Resch; Lydia Aldaz-Carroll; Roselyn J Eisenberg; Gary H Cohen; Bernard Moss
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

4.  A turn-like structure "KKPE" segment mediates the specific binding of viral protein A27 to heparin and heparan sulfate on cell surfaces.

Authors:  Ping-Chen Shih; Min-Shiang Yang; Su-Ching Lin; Yu Ho; Jye-Chian Hsiao; Da-Rong Wang; Steve S-F Yu; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

5.  Vaccinia virus exhibits cell-type-dependent entry characteristics.

Authors:  J Charles Whitbeck; Chwan-Hong Foo; Manuel Ponce de Leon; Roselyn J Eisenberg; Gary H Cohen
Journal:  Virology       Date:  2009-01-21       Impact factor: 3.616

6.  Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans.

Authors:  Chwan Hong Foo; Huan Lou; J Charles Whitbeck; Manuel Ponce-de-León; Doina Atanasiu; Roselyn J Eisenberg; Gary H Cohen
Journal:  Virology       Date:  2009-01-21       Impact factor: 3.616

7.  Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp.

Authors:  Elizabeth A Rogers; Richard T Marconi
Journal:  Infect Immun       Date:  2007-09-10       Impact factor: 3.441

8.  Crystal structure of vaccinia viral A27 protein reveals a novel structure critical for its function and complex formation with A26 protein.

Authors:  Tao-Hsin Chang; Shu-Jung Chang; Fu-Lien Hsieh; Tzu-Ping Ko; Cheng-Tse Lin; Meng-Ru Ho; Iren Wang; Shang-Te Danny Hsu; Rey-Ting Guo; Wen Chang; Andrew H J Wang
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

9.  Systems integration of biodefense omics data for analysis of pathogen-host interactions and identification of potential targets.

Authors:  Peter B McGarvey; Hongzhan Huang; Raja Mazumder; Jian Zhang; Yongxing Chen; Chengdong Zhang; Stephen Cammer; Rebecca Will; Margie Odle; Bruno Sobral; Margaret Moore; Cathy H Wu
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

10.  Protective effect of surfactant protein d in pulmonary vaccinia virus infection: implication of A27 viral protein.

Authors:  Julien Perino; Nicole M Thielens; Erika Crouch; Danièle Spehner; Jean-Marc Crance; Anne-Laure Favier
Journal:  Viruses       Date:  2013-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.